{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:01:45Z","timestamp":1792760505620,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jemermed.2017.12.048","type":"journal-article","created":{"date-parts":[[2018,1,20]],"date-time":"2018-01-20T17:18:42Z","timestamp":1516468722000},"page":"807-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department: A Review of the Literature"],"prefix":"10.1016","volume":"54","author":[{"given":"Michael","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2017.12.048_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00148581-200507010-00002","article-title":"Toxic shock syndrome in children: epidemiology, pathogenesis, and management","volume":"7","author":"Chuang","year":"2005","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jemermed.2017.12.048_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1993.03500030082037","article-title":"The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study","volume":"269","author":"Hoge","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.12.048_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/514632","article-title":"Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment","volume":"27","author":"Zurawski","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3201\/eid0804.010278","article-title":"Invasive group a streptococcal infections, Israel","volume":"8","author":"Moses","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1086\/341409","article-title":"Epidemiology of invasive group a streptococcus disease in the United States, 1995\u20131999","volume":"35","author":"O'Brien","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/JCM.43.4.1678-1683.2005","article-title":"Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002)","volume":"43","author":"Tyrrell","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1469-0691.2004.01068.x","article-title":"Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994\u20132003","volume":"1","author":"Vlaminckx","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jemermed.2017.12.048_bib9","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1348-0421.12539","article-title":"Prevalence, comorbidities and mortality of toxic shock syndrome in children and adults in the USA","volume":"61","author":"Strom","year":"2017","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/00365549009027073","article-title":"Streptococcal serogroup A epidemic in Norway 1987\u20131988","volume":"22","author":"Martin","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1469-0691.2005.01345.x","article-title":"Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region","volume":"12","author":"Laupland","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jemermed.2017.12.048_bib13","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1086\/318148","article-title":"Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae","volume":"31","author":"Tang","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10096-006-0106-2","article-title":"Group B streptococcal toxic shock syndrome in an asplenic patient: case report and literature review","volume":"25","author":"Sims","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jiac.2014.12.002","article-title":"Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013","volume":"21","author":"Ikebe","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jemermed.2017.12.048_bib16","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2169\/internalmedicine.55.6787","article-title":"Recurrent Streptococcus agalactiae toxic shock syndrome triggered by a tumor necrosis factor-\u03b1 inhibitor","volume":"55","author":"Yoshida","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjms.2016.04.002","article-title":"Toxic shock syndrome: an unusual organism","volume":"352","author":"Young","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jemermed.2017.12.048_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1752-1947-1-118","article-title":"Surviving streptococcal toxic shock syndrome: a case report","volume":"1","author":"Madhusudhan","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jemermed.2017.12.048_bib19","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1128\/JCM.42.6.2866-2869.2004","article-title":"Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin","volume":"42","author":"Korman","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3201\/eid2301.161009","article-title":"Streptococcal toxic shock syndrome caused by Group G streptococcus, United Kingdom","volume":"23","author":"Baxter","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/344464","article-title":"Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease","volume":"35","author":"Sinave","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","article-title":"Toxic-shock syndrome associated with phage-group-I Staphylococci","volume":"2","author":"Todd","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2017.12.048_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","article-title":"Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention","volume":"303","author":"Davis","year":"1980","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2017.12.048_bib24","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/clinids\/11.Supplement_1.S35","article-title":"Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study","volume":"11","author":"Reingold","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid0506.990611","article-title":"Toxic shock syndrome in the United States: surveillance update, 1979\u20131996","volume":"5","author":"Hajjeh","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0891-5520(05)70324-X","article-title":"The toxic shock syndromes","volume":"10","author":"Stevens","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jemermed.2017.12.048_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jiph.2012.07.006","article-title":"Group A streptococcus toxic shock syndrome: an outbreak report and review of the literature","volume":"5","author":"Al-ajmi","year":"2012","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jemermed.2017.12.048_bib28","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1111\/1346-8138.14014","article-title":"Case of toxic shock syndrome triggered by negative-pressure wound therapy","volume":"44","author":"Tomura","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.idcr.2017.07.004","article-title":"Toxic shock syndrome caused by suture abscess with methicillin-resistant Staphylococcus aureus (MRSA) with late onset after Caesarean section","volume":"10","author":"Komuro","year":"2017","journal-title":"IDCases"},{"key":"10.1016\/j.jemermed.2017.12.048_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.annemergmed.2009.05.030","article-title":"Fatal toxic shock syndrome from an intrauterine device","volume":"54","author":"Klug","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jemermed.2012.03.020","article-title":"Fatal streptococcal toxic shock syndrome from an intrauterine device","volume":"44","author":"Cho","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0305-4179(99)00142-4","article-title":"A survey into toxic shock syndrome (TSS) in UK burns units","volume":"26","author":"Edwards-Jones","year":"2000","journal-title":"Burns"},{"key":"10.1016\/j.jemermed.2017.12.048_bib33","doi-asserted-by":"crossref","first-page":"1735.e1","DOI":"10.1016\/j.ajem.2015.12.060","article-title":"Toxic shock syndrome due to methicillin-resistant Staphylococcus aureus infection after a pediatric scald burn","volume":"34","author":"Garland","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.burns.2017.07.002","article-title":"Toxic shock syndrome in paediatric thermal injuries: a case series and systematic literature review","volume":"44","author":"Gutzler","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.jemermed.2017.12.048_bib35","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/bmj.332.7554.1376","article-title":"New football boots and toxic shock syndrome","volume":"332","author":"Taylor","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jemermed.2017.12.048_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.1987.03390080043027","article-title":"Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness","volume":"257","author":"MacDonald","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.12.048_bib37","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2169\/internalmedicine.51.7295","article-title":"Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)","volume":"51","author":"Kashiwada","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MEJ.0b013e3282f08d3d","article-title":"Fatal streptococcal toxic shock syndrome in a child with varicella and necrotizing fasciitis of the face","volume":"15","author":"Minodier","year":"2008","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00431-010-1337-x","article-title":"Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units","volume":"170","author":"Rodr\u00edguez-Nu\u00f1ez","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jemermed.2017.12.048_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-695X.2011.00788.x","article-title":"Invasive group A streptococcal disease and association with varicella in Germany, 1996\u20132009","volume":"62","author":"Im\u00f6hl","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jemermed.2017.12.048_bib42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/infdis\/167.5.997","article-title":"Role of superantigens in human disease","volume":"167","author":"Schlievert","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.8.3.411","article-title":"Bacterial pyrogenic exotoxins as superantigens","volume":"8","author":"Kotb","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jemermed.2017.12.048_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","article-title":"Molecular basis of group A streptococcal virulence","volume":"3","author":"Bisno","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes","volume":"9","author":"Lappin","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/653116","article-title":"Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections","volume":"51","author":"Johansson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11908-010-0119-y","article-title":"Staphylococcal toxic shock syndrome: mechanisms and management","volume":"12","author":"Silversides","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jemermed.2017.12.048_bib50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/infdis\/150.5.662","article-title":"Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers","volume":"150","author":"Bonventre","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/315222","article-title":"Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies","volume":"181","author":"Mascini","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib52","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/148.4.692","article-title":"Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome","volume":"148","author":"Vergeront","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/151.5.883","article-title":"Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin","volume":"151","author":"Stolz","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib54","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/JCM.43.9.4628-4634.2005","article-title":"Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women","volume":"43","author":"Parsonnet","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/314872","article-title":"Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome","volume":"180","author":"Eriksson","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib57","first-page":"1","article-title":"Case definitions for public health surveillance","volume":"39","author":"Wharton","year":"1990","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jemermed.2017.12.048_bib58","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jemermed.2017.12.048_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib60","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJM198012183032502","article-title":"Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases","volume":"303","author":"Shands","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib61","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-96-6-871","article-title":"Nonmenstrual toxic shock syndrome: a review of 130 cases","volume":"96","author":"Reingold","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jama.1981.03320070025019","article-title":"Clinical manifestations of toxic shock syndrome","volume":"246","author":"Chesney","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.12.048_bib63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10408419009105728","article-title":"Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses","volume":"17","author":"Bohach","year":"1990","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib64","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.1981.03320190021019","article-title":"Toxic shock syndrome. Evidence of a broad clinical spectrum","volume":"246","author":"Tofte","year":"1981","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2017.12.048_bib65","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/clinids\/11.Supplement_1.S1","article-title":"Clinical aspects and spectrum of illness of toxic shock syndrome: overview","volume":"11","author":"Chesney","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0163-4453(86)94424-5","article-title":"Toxic shock syndrome presenting as encephalopathy","volume":"12","author":"Barrett","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.jemermed.2017.12.048_bib67","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1227\/00006123-198803000-00030","article-title":"Fatal cerebral edema complicating toxic shock syndrome","volume":"22","author":"Smith","year":"1988","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jemermed.2017.12.048_bib68","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-96-6-865","article-title":"Persistent neuropsychological sequelae of toxic shock syndrome","volume":"96","author":"Rosene","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections of skin and soft tissues","volume":"334","author":"Bisno","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","article-title":"Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden","volume":"45","author":"Darenberg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib71","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/320170","article-title":"Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment","volume":"32","author":"Andrews","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.sap.0000154874.89277.a4","article-title":"Streptococcal toxic shock syndrome after breast reconstruction","volume":"54","author":"Agerson","year":"2005","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jemermed.2017.12.048_bib73","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1988.00380060185032","article-title":"'Toxic strep syndrome'. A manifestation of group A streptococcal infection","volume":"148","author":"Bartter","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib74","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0016-5085(81)80120-5","article-title":"Acute cholestasis in patients with toxic- shock syndrome","volume":"81","author":"Gourley","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jemermed.2017.12.048_bib75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/76.5.619","article-title":"Cryptogenic acute cholangitis\u2014association with toxic shock syndrome","volume":"76","author":"Ishak","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9343(81)90210-2","article-title":"Renal manifestations of the staphylococcal toxic-shock syndrome","volume":"71","author":"Chesney","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib77","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","year":"1993","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1016\/j.jemermed.2017.12.048_bib78","first-page":"S106","article-title":"Recognition and management of Staphylococcus aureus toxin-mediated disease","volume":"35","author":"Murray","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.jemermed.2017.12.048_bib79","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4065\/76.11.1167","article-title":"Waterhouse-Friderichsen syndrome after infection with group A streptococcus","volume":"76","author":"Karakousis","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"45","key":"10.1016\/j.jemermed.2017.12.048_bib80","first-page":"486","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock","volume":"2017","author":"Rhodes","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2017.12.048_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.idcr.2017.04.012","article-title":"Toxic shock syndrome due to community-acquired methicillin-resistant Staphylococcus aureus infection: Two case reports and a literature review in Japan","volume":"8","author":"Sada","year":"2017","journal-title":"IDCases"},{"key":"10.1016\/j.jemermed.2017.12.048_bib82","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1651-2227.2005.tb01979.x","article-title":"Streptococcal toxic shock syndrome in children without skin and soft tissue infection: report of four cases","volume":"94","author":"Chiang","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jemermed.2017.12.048_bib83","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3201\/eid1104.040893","article-title":"Methicillin-resistant Staphylococcus aureus toxic shock syndrome","volume":"11","author":"Jamart","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/500265","article-title":"Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in\u00a0vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib85","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/AOG.0b013e3181866468","article-title":"Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus","volume":"112","author":"Andrews","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejogrb.2009.02.040","article-title":"Postpartum toxic shock syndrome due to methicillin-resistant Staphylococcus aureus epidemic in community","volume":"144","author":"Collet","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib87","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/ecp.10.121","article-title":"New insights into the prevention of staphylococcal infections and toxic shock syndrome","volume":"3","author":"Lin","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jemermed.2017.12.048_bib88","doi-asserted-by":"crossref","first-page":"e22997","DOI":"10.1371\/journal.pone.0022997","article-title":"Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics","volume":"6","author":"DeVries","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jemermed.2017.12.048_bib89","first-page":"e2","article-title":"Toxic shock syndrome caused by methicillin-resistant Staphylococcus aureus (MRSA) after expander-based breast reconstruction","volume":"16","author":"Suga","year":"2016","journal-title":"Eplasty"},{"key":"10.1016\/j.jemermed.2017.12.048_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis","volume":"158","author":"Stevens","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jemermed.2017.12.048_bib92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci","volume":"18","author":"Mascini","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jemermed.2017.12.048_bib93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linn\u00e9r","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib94","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","article-title":"Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A eelease","volume":"47","author":"Coyle","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jemermed.2017.12.048_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/BCR.0b013e318280e35a","article-title":"Treatment with an oxazolidinone antibiotic inhibits toxic shock syndrome toxin-1 production in MRSA-infected burn wounds","volume":"34","author":"Shupp","year":"2013","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jemermed.2017.12.048_bib96","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jemermed.2017.12.048_bib97","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib98","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/jama.1992.03480240077038","article-title":"Intravenous immunoglobulin therapy for toxic shock syndrome","volume":"267","author":"Barry","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.12.048_bib99","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/clinids\/21.6.1469","article-title":"Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review","volume":"21","author":"Lamothe","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib102","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00365540310015944","article-title":"Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections","volume":"35","author":"Norrby-Teglund","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib103","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/00365540410020866","article-title":"Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach","volume":"37","author":"Norrby-Teglund","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"4 suppl","key":"10.1016\/j.jemermed.2017.12.048_bib104","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1067\/mai.2001.117820","article-title":"Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses","volume":"108","author":"Schlievert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jemermed.2017.12.048_bib105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1086\/606049","article-title":"Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest","volume":"49","author":"Valiquette","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2017.12.048_bib106","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2146\/ajhp140359","article-title":"Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection","volume":"72","author":"Shah","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jemermed.2017.12.048_bib107","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1001\/jama.1984.03350240045037","article-title":"Corticosteroid therapy for patients with toxic shock syndrome","volume":"252","author":"Todd","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.12.048_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1752-1947-1-5","article-title":"Toxic shock syndrome responsive to steroids","volume":"1","author":"Vergis","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jemermed.2017.12.048_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00024382-199602000-00011","article-title":"Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration","volume":"5","author":"Bottoms","year":"1996","journal-title":"Shock"},{"key":"10.1016\/j.jemermed.2017.12.048_bib110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","article-title":"A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection","volume":"23","author":"Vincent","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.jemermed.2017.12.048_bib111","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/SHK.0b013e318188dec5","article-title":"Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock","volume":"31","author":"Sykora","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.jemermed.2017.12.048_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/SHK.0b013e3182429b38","article-title":"Biological and technical considerations regarding the removal of bacteriotoxins in sepsis with emphasis on toxic shock syndrome toxin 1","volume":"37","author":"Brummelhuis","year":"2012","journal-title":"Shock"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467917312143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467917312143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:34Z","timestamp":1760028034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467917312143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0736467917312143"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2017.12.048","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department: A Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2017.12.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}